The mRNA field is on the cusp of revolutionary change, with cancer vaccines, in vivo cell engineering and gene editing technologies unleashing the next advancements of therapeutic candidates and developmental progress towards […]

This July, the 13th Tumor Models Summit Boston returns, uniting 180+ preclinical and translational experts from biopharma and solution providers. This year’s dual-track program will empower you and your team […]